Viral Hepatitis C - Anadys Pharmaceuticals Initiates Clinical Trials

Anadys Pharmaceuticals Initiates Clinical Trials
NAMC Newswire Releases (press release), CA - Dec 24, 2005... made an announcement today that it plans to initiate a Phase Ib, placebo-controlled, multiple-dose clinical trial of ANA975 in chronic hepatitis C patients in ...

Liver Cancer, Hepatitis C Connection Gets Clearer
WFIE-TV, IN - Dec 7, 20057 (HealthDay News) -- Scientists have long noted a link between chronic hepatitis C infection and an increased risk for liver cancer, and a new study may help ...

ANGER OVER `LOW-KEY' LIVER REPORT
Community Newswire, UK - Dec 20, 2005... The report estimates there are currently 4,500 people in the UK living with severe liver disease as a result of having a chronic hepatitis C infection and ...

Anadys Pharmaceuticals to Present at the 24th Annual JP Morgan ...
PR Newswire (press release), NY - Jan 5, 2006... of 501, 502 and 503 clinical studies of ANA975 in healthy volunteers * Upcoming 28-day study of ANA975 in patients with chronic hepatitis C virus (HCV ...

FDA Grants Fast Track Designation to Vertex's Investigational Oral ...
PR Newswire (press release), NY - Dec 8, 2005... The FDA granted Fast Track designation to VX-950 for the following reasons: * Chronic hepatitis C virus infection is a serious and life-threatening disease. ...